Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-14-010033
Filing Date
2014-06-09
Accepted
2014-06-09 17:09:18
Documents
1
Period of Report
2014-06-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3525
  Complete submission text file 0001179110-14-010033.txt   4950
Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103 901-523-9700
GTX INC /DE/ (Issuer) CIK: 0001260990 (see all company filings)

EIN.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 175 TOYOTA PLAZA 7TH FLOOR MEMPHIS TN 38103
Business Address
DALTON JAMES T (Reporting) CIK: 0001314981 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50549 | Film No.: 14899799